The Peptide Split: How GLP 1s, Lutathera, Vosoritide, and Peptide Cancer Vaccines Are Quietly Rewriting Medicine While BPC 157, TB 500, MOTS c, and the Wellness Grift Borrow Their Halo They Call It the 'Wolverine Peptide.' And Everyone from Biohackers to Your Dad Wants It Now. BPC 157 has already hit the mainstream, but should it hit your bloodstream? The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The science behind the peptide craze Scientific American